Gain-of-function mutations in the transient receptor potential cation channel TRPC6 are associated with the onset of familial forms of FSGS and increased expression of this channel has been described in acquired glomerular disorders including DN (23, 24). The gene discussed is TRPC6; the disease is liver dysplastic nodule.